Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer

We used KRAS mutations to investigate the clinical relevance of circulating tumor DNA (ctDNA) measurements in patients with advanced pancreatic cancer. Fifty‐three blood samples were collected from 14 prospectively recruited patients prior to chemotherapy (gemcitabine or FOLFIRINOX) and subsequently...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Oncol
Autori principali: Tjensvoll, Kjersti, Lapin, Morten, Buhl, Tove, Oltedal, Satu, Steen-Ottosen Berry, Katrine, Gilje, Bjørnar, Søreide, Jon Arne, Javle, Millind, Nordgård, Oddmund, Smaaland, Rune
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2015
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5423145/
https://ncbi.nlm.nih.gov/pubmed/26725968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.11.012
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi